Handel nachbörslich: 13.38 -0.12 -0.89%

Third Harmonic Bio Inc (THRD)

Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten

Third Harmonic Bio Inc (THRD)

Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten

WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga

Long Term Trading Analysis for (THRD) - Stock Traders Daily

Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa

Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com Australia

Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia

Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Canada

Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India

Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com

Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World

Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat

How the (HRMY) price action is used to our Advantage - Stock Traders Daily

Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily

23andMe faces Nasdaq delisting - MSN

Independent directors resign from 23andMe board after opposing move to privatize - Washington Times

23andMe Stock Falls as All Board Members Resign - Barron's

Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins

Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle

ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire

23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24

23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24

Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World

Hex And PulseChain Founder Richard Heart In Hot Water With Finnish Authorities - Cryptonews

23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki - The Wall Street Journal

Crypto Influencer Richard Heart Investigated for Tax Evasion - Crypto Times

23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private - New York Post

Check Out Hyliion Holdings Corporation (HYLN)’s Trade Data Rather Than the Analysts’ Views - SETE News

A Look at Harmonic, Inc. (HLIT) Shares in the Recent Past Indicates Growth - SETE News

Finnish Police Seeking Hex Founder Richard Heart for Suspected Gross Tax Evasion, Assault - Decrypt

Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - Yahoo Finance

23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MarketWatch

23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid - MarketWatch

23andMe down after independent directors quit board - XM

Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - BNN Bloomberg

Raymond James analysts upgrades a Strong buy rating for Harmonic, Inc. (HLIT) - Knox Daily

Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs - BioPharma Dive

Hyliion Holdings Corporation (HYLN) did well last session? - US Post News

HashiCorp Inc (HCP) Becoming More Attractive for Investors - Knox Daily

Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business - Yahoo Finance

Commonwealth Equity Services LLC Trims Stake in Haleon plc (NYSE:HLN) - Defense World

Three biotechs raise $700M in rare burst of IPO activity - BioPharma Dive

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September - StockTitan

Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease - BioPharma Dive

ArsenalBio raises $325M in one of the year’s largest biotech funding rounds - BioPharma Dive

This trade activity should not be overlooked: Third Harmonic Bio Inc (THRD) - SETE News

Learn to Evaluate (THRD) using the Charts - Stock Traders Daily

Third Harmonic Bio to Participate in Upcoming Investor Conferences - Yahoo Finance UK

Third Harmonic Bio to Participate in Upcoming Investor Conferences - StockTitan

BridgeBio sends rare disease drugs to new company - BioPharma Dive

Morgan Stanley Upgrades Third Harmonic Bio (THRD) - MSN

Morgan Stanley raises Third Harmonic Bio stock rating to Overweight By Investing.com - Investing.com Canada

Here are Friday's biggest analyst calls: Nvidia, Amazon, Chipotle, Uber, Eli Lilly, Sweetgreen, Burlington, Synchrony & more - Head Topics

Third Harmonic Loses On Q2 Financials - MENAFN.COM

Third Harmonic Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Third Harmonic Loses on Q2 Financials - Baystreet.ca

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update - StockTitan

How to Take Advantage of moves in (THRD) - Stock Traders Daily

Companies Like Third Harmonic Bio (NASDAQ:THRD) Can Afford To Invest In Growth - Simply Wall St

(THRD) Trading Advice - Stock Traders Daily

Private biotech M&A surges amid difficult IPO market - BioPharma Dive

Esperion Therapeutics (NASDAQ:ESPR) Stock Quotes, Forecast and News Summary - Benzinga

Artiva prices $167M IPO, riding optimism for autoimmune cell therapy - BioPharma Dive

SNDL (NASDAQ:SNDL) Stock Quotes, Forecast and News Summary - Benzinga

SciRhom pulls in $70M for a new type of immune disease drug - BioPharma Dive

(THRD) Investment Analysis - Stock Traders Daily

Harrow (NASDAQ:HROW) Stock Quotes, Forecast and News Summary - Benzinga

Third Harmonic Bio Inc (THRD) looking to reclaim success with recent performance – Sete News - SETE News

Chronic Urticaria Or Hives – Drugs In Development, 2024 - GlobalData

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Quantisnow

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference - Quantisnow

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results - Quantisnow

Ähnlich wie THRD